CastleKnight Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-30,000
Closed -$5.66M 557
2026
Q1
$5.66M Hold
30,000
0.09% 146
2025
Q4
$5.96M Sell
30,000
-140,000
-82% -$28.3M 0.13% 97
2025
Q3
$34.5M Buy
170,000
+100,000
+143% +$17.7M 0.68% 20
2025
Q2
$12.3M Buy
+70,000
New +$10.5M 0.35% 44
2024
Q3
Sell
-20,000
Closed -$2.66M 405
2024
Q2
$2.66M Sell
20,000
-10,000
-33% -$1.2M 0.13% 120
2024
Q1
$3.15M Sell
30,000
-10,000
-25% -$899K 0.19% 86
2023
Q4
$3.02M Buy
+40,000
New +$2.54M 0.16% 79

Other funds holding THC

CastleKnight Management's THC Position: Q2 2026 in Review

CastleKnight Management increased its Tenet Healthcare (THC) stake by 83% in Q2 2026, buying an estimated $5.5M and bringing the position to 66,100 shares worth $12.4M. The position accounts for 0.17% of the portfolio, ranked #92.

CastleKnight Management first reported a position in THC in Q1 2022 and has held it in 18 quarters since. The position peaked at $15M in Q3 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • CastleKnight Management held 66,100 shares of Tenet Healthcare worth $12.4M as of Q2 2026.
  • CastleKnight Management bought 29,900 Tenet Healthcare shares in Q2 2026, an estimated $5.5M.
  • Tenet Healthcare made up 0.17% of CastleKnight Management's portfolio in Q2 2026, its #92 holding.
  • CastleKnight Management first reported a position in Tenet Healthcare in Q1 2022 and has held it in 18 quarters since.
  • CastleKnight Management's Tenet Healthcare position peaked at $15M in Q3 2025.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on CastleKnight Management's 13F filing for Q2 2026, filed 14 Aug 2026.